COVAD survey 2 long-term outcomes: unmet need and protocol

Document detail

ID

doi:10.1007/s00296-022-05157-6...

Author

Fazal, Zoha Zahid Sen, Parikshit Joshi, Mrudula Ravichandran, Naveen Lilleker, James B. Agarwal, Vishwesh Kardes, Sinan Kim, Minchul Day, Jessica Makol, Ashima Milchert, Marcin Gheita, Tamer Salim, Babur Velikova, Tsvetelina Gracia-Ramos, Abraham Edgar Parodis, Ioannis Nikiphorou, Elena Tan, Ai Lyn Chatterjee, Tulika Cavagna, Lorenzo Saavedra, Miguel A. Shinjo, Samuel Katsuyuki Ziade, Nelly Selva-O’Callaghan, Albert Nune, Arvind Knitza, Johannes Kuwana, Masataka Gutiérrez, Carlos-Enrique Toro Caballero-Uribe, Carlo Vinicio Dey, Dzifa Distler, Oliver Chinoy, Hector Agarwal, Vikas Aggarwal, Rohit Gupta, Latika COVAD Study Group

Langue

Editor

Springer

Year

2022

listing date

8/17/2022

Keywords

covid-19 registries vaccination long-term adverse effects autoimmune diseases long-term vaccination survey

Metrics

Abstract

Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19.

While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, equitable vaccine uptake remains the foremost strategy to manage pandemic.

Although none of the currently approved vaccines are live-attenuated, several reports of disease flares, waning protection, and acute-onset syndromes have emerged as short-term adverse events after vaccination.

Hence, scientific literature falls short when discussing potential long-term effects in vulnerable cohorts.

The COVAD-2 survey follows on from the baseline COVAD-1 survey with the aim to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation.

The e-survey has been extensively pilot-tested and validated with translations into multiple languages.

Anticipated results will help improve vaccination efforts and reduce the imminent risks of COVID-19 infection, especially in understudied vulnerable groups.

Fazal, Zoha Zahid,Sen, Parikshit,Joshi, Mrudula,Ravichandran, Naveen,Lilleker, James B.,Agarwal, Vishwesh,Kardes, Sinan,Kim, Minchul,Day, Jessica,Makol, Ashima,Milchert, Marcin,Gheita, Tamer,Salim, Babur,Velikova, Tsvetelina,Gracia-Ramos, Abraham Edgar,Parodis, Ioannis,Nikiphorou, Elena,Tan, Ai Lyn,Chatterjee, Tulika,Cavagna, Lorenzo,Saavedra, Miguel A.,Shinjo, Samuel Katsuyuki,Ziade, Nelly,Selva-O’Callaghan, Albert,Nune, Arvind,Knitza, Johannes,Kuwana, Masataka,Gutiérrez, Carlos-Enrique Toro,Caballero-Uribe, Carlo Vinicio,Dey, Dzifa,Distler, Oliver,Chinoy, Hector,Agarwal, Vikas,Aggarwal, Rohit,Gupta, Latika,COVAD Study Group, 2022, COVAD survey 2 long-term outcomes: unmet need and protocol, Springer